Although the ondansetron group demonstrated a lower prevalence of postoperative nausea and vomiting ( PONV ) ( 24 % nausea and 10 % vomiting ) than the placebo group ( 31 % nausea and 17 % vomiting ) , significant reduction in postoperative vomiting only occurred in the first postoperative hour ( p = 0.038 ) .
